Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P53 null mice: damaging the hypothesis?

O J Sansom1, A R Clarke

  • 1Department of Pathology, Medical School, Teviot Place, University of Edinburgh, EH8 9AG Edinburgh, UK.

Mutation Research
|October 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium.

Oncogene·2024
Same author

A comprehensive phylogeny helps clarify the evolutionary history of host breadth and lure response in the Australian Dacini fruit flies (Diptera: Tephritidae).

Molecular phylogenetics and evolution·2022
Same author

A RAC-GEF network critical for early intestinal tumourigenesis.

Nature communications·2021
Same author

Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptors.

Nature communications·2020
Same author

Pancreatic Cancer: From Genome Discovery to PRECISION-Panc.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Microenvironmental cues in cancer stemness.

Nature cell biology·2018
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

The tumor suppressor protein p53 (p53) plays a role in preventing cancer. However, its exact function in apoptosis and tumor suppression requires further investigation beyond a simple gatekeeper model.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The tumor suppressor gene p53 is extensively studied for its role in cancer prevention.
  • Despite significant research, the precise in vivo functions of p53, particularly in apoptosis induction, remain incompletely understood.
  • The hypothesis that p53 deficiency leads to the accumulation of DNA-damaged cells, initiating malignancy, is a key area of investigation.

Purpose of the Study:

  • To critically review the evidence supporting and refuting the hypothesis that p53 deficiency drives cancer by preventing apoptosis.
  • To elucidate the specific roles of p53-dependent apoptosis in tumor suppression.
  • To examine the complex interplay between p53, apoptosis, and carcinogenesis, using murine intestinal studies as a model.

Main Methods:

Related Experiment Videos

  • Literature review of studies investigating p53 function in vivo.
  • Analysis of data from murine intestinal models focusing on DNA damage, apoptosis, and tumor formation.
  • Synthesis of evidence for and against the p53-deficiency-induced apoptosis hypothesis.

    • Main Results:

    • Data from murine intestinal studies present a complex picture regarding p53's role in apoptosis and tumor suppression.
    • While some evidence supports the hypothesis that p53 deficiency promotes malignancy through impaired apoptosis, numerous counterexamples exist.
    • The abrogation of p53-dependent apoptosis appears to influence carcinogenesis and neoplastic progression.

    Conclusions:

    • The notion of p53 as the sole gatekeeper of apoptosis in tumor suppression is an oversimplification.
    • p53's role in apoptosis is critical but operates within a complex network of cellular processes influencing cancer development.
    • Further research is needed to fully delineate the multifaceted functions of p53 in preventing and progression of cancer.